Overview
Federal Regulations
All
Driver
Vehicle
Company
FMCSA Hazmat
Regulatory Guidance
Rulemakings and Notices
Final Rules
Interim Final Rules
Proposed Rules
Notices
Topics of Interest
Hours-of-Service (HOS) Summary
Distracted Driving
Hazardous Materials
Intermodal Equipment Providers (IEP)
New Entrant Safety Assurance
Medical Program
Medical Expert Panels
NAFTA Rules
Drug & Alcohol Testing
 
  
 

Interpretation for 382.503:

Regulations current to Apr 12, 2013
         
Examples: Medical Form, 391.53, 391
 
Up All Regulations
Up Part 382
 
< 382.501 382.505 >
Subpart E - Consequences for drivers engaging in substance use-related conduct

ยง382.503 Required evaluation and testing.

Question 1: If (1) a driver has a verified positive test result for controlled substances or an alcohol concentration of 0.04 or greater and (2) the driver subsequently obtains a verified negative result for controlled substances or a test result of less than 0.04 alcohol concentration without having been evaluated by a substance abuse professional (SAP), may the motor carrier accept the subsequent test results and ignore the requirement to refer the driver to an SAP for evaluation and possible treatment?

Guidance: No. A motor carrier must have a report from an SAP showing that the driver has been evaluated and may return to work because he or she:

(1) Does not need treatment;

(2) Needs part-time outpatient treatment, but may continue to drive while being treated on his or her off duty time; or

(3) Needed full-time outpatient or inpatient treatment, has received such treatment, and is ready to return to driving.

The driver must also pass a return to duty controlled substances or alcohol test that complies with all of the requirements of parts 40 and 382.


 
 
Connect with us
FMCSA's Contact Us  FMCSA's Facebook page

Feedback | Privacy Policy | USA.gov | Freedom of Information Act (FOIA) | Accessibility | OIG Hotline | Web Policies and Important Links | Site Map | Plug-ins

Federal Motor Carrier Safety Administration
1200 New Jersey Avenue SE, Washington, DC 20590 • 1-800-832-5660 • TTY: 1-800-877-8339 • Field Office Contacts